| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 23, 2007
From the Department of Physiology and Pharmacology, Northeastern Ohio Universities College of Medicine, Rootstown; and the Graduate Program, School of Biomedical Sciences, Kent State University, Kent, Ohio. * To whom correspondence should be addressed. E-mail: jgmeszar{at}neoucom.edu.
Abstract—Angiotensin II (Ang II)–induced proliferation of cardiac fibroblasts is a major contributing factor to the pathogenesis of cardiac fibrosis. Ang II activates extracellular signal–regulated kinase (ERK) 1/2 to induce cardiac fibroblast proliferation, but the signaling pathways leading to ERK 1/2 activation have not been elucidated in these cells. The goal of the current study was to identify the intracellular mediators of Ang II–induced ERK 1/2 activation in adult rat cardiac fibroblasts. We determined that 100 nmol/L of Ang II–induced ERK 1/2 phosphorylation is inhibited by simultaneous chelation of cytosolic calcium and downregulation of protein kinase C (PKC) by phorbol ester or by the specific PKC
Revised on August 17, 2007
Angiotensin II–Induced Extracellular Signal–Regulated Kinase 1/2 Activation Is Mediated by Protein Kinase C
Erik R. Olson;
and Intracellular Calcium in Adult Rat Cardiac Fibroblasts
inhibitor rottlerin, as well as PKC
small interfering RNA, but not by inhibition of 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetate, phorbol ester, rottlerin, or PKC
small interfering RNA alone. We also found that Ang II does not transactivate the epidermal growth factor receptor in adult cardiac fibroblasts, because pretreatment with 1 µmol/L of AG 1478 did not significantly inhibit [3H]-thymidine incorporation or ERK 1/2 activation. In addition, immunoprecipitation of the epidermal growth factor receptor demonstrated no significant Ang II–induced phosphorylation of tyrosine residues. Inhibition of phosphatidylinositide 3-kinase, PKC
, and src tyrosine kinase had no effect on Ang II–induced ERK 1/2 activation. Collectively, these data demonstrate that Ang II does not transactivate the epidermal growth factor receptor in adult rat cardiac fibroblasts to activate ERK 1/2, a common pathway described in vascular smooth muscle and other cell types, but rather occurs via activation of distinct parallel signaling pathways mechanistically controlled by intracellular Ca2+ and PKC
.
This article has been cited by other articles:
![]() |
P. E. Shamhart, D. J. Luther, B. R. Hodson, J. C. Koshy, V. Ohanyan, and J. G. Meszaros Impact of type 1 diabetes on cardiac fibroblast activation: enhanced cell cycle progression and reduced myofibroblast content in diabetic myocardium Am J Physiol Endocrinol Metab, November 1, 2009; 297(5): E1147 - E1153. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Villarreal, S. A. Epperson, I. Ramirez-Sanchez, K. G. Yamazaki, and L. L. Brunton Regulation of cardiac fibroblast collagen synthesis by adenosine: roles for Epac and PI3K Am J Physiol Cell Physiol, May 1, 2009; 296(5): C1178 - C1184. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ying, P. Yue, X. Xu, M. Zhong, Q. Sun, M. Mikolaj, A. Wang, R. D. Brook, L. C. Chen, and S. Rajagopalan Air pollution and cardiac remodeling: a role for RhoA/Rho-kinase Am J Physiol Heart Circ Physiol, May 1, 2009; 296(5): H1540 - H1550. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Palaniyandi, L. Sun, J. C. B. Ferreira, and D. Mochly-Rosen Protein kinase C in heart failure: a therapeutic target? Cardiovasc Res, May 1, 2009; 82(2): 229 - 239. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lijnen Angiotensin II-Induced Proliferation of Neonatal and Adult Rat Cardiac Fibroblasts Hypertension, June 1, 2008; 51(6): e50 - e50. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2008 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |